US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 22.950
  • -0.210-0.91%
Trading Dec 19 13:28 ET
1.35BMarket Cap-15.30P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spyre Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.000M--
--2024/Q4-- / 2.333M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 2.857M--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.000M--
--2024/Q4-- / 2.333M--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 2.857M--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Spyre Therapeutics Earnings Reports

  • Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 18 16:15 ET

  • Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 18 16:12 ET

  • Spyre Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 18 16:11 ET

  • Spyre Therapeutics | 10-K/A: Annual report (Amendment)

    Nov 18 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 19, 2024

    Strong Buy

    • Buy

      85.71%

    • Hold

      14.29%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data